Cargando…
1481. Clinical Outcomes of Escherichia coli Infections in Cystic Fibrosis (CF) Patients
BACKGROUND: Despite a growing interest in emerging pathogens in CF, research has largely overlooked commonplace organisms. Escherichia coli has been reported in up to 50% of CF respiratory samples, yet little is known about its clinical impact. We sought to investigate outcomes of E. coli infection...
Autores principales: | Edwards, Brett, Greysson-Wong, Jasper, Somayaji, Ranjani, Waddell, Barbara, Storey, Doug, Surette, Michael, Rabin, Harvey, Parkins, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6252733/ http://dx.doi.org/10.1093/ofid/ofy210.1310 |
Ejemplares similares
-
Epidemiology of E. coli in Cystic Fibrosis Airways Demonstrates the Capacity for Persistent Infection but Not Patient-Patient Transmission
por: Izydorczyk, Conrad, et al.
Publicado: (2020) -
Clinical Outcomes Associated With Escherichia coli Infections in Adults With Cystic Fibrosis: A Cohort Study
por: Edwards, B D, et al.
Publicado: (2019) -
Clinical implications and characterization of Group A Streptoccoccus infections in adults with cystic fibrosis
por: Skolnik, Kate, et al.
Publicado: (2015) -
Azithromycin and the microbiota of cystic fibrosis sputum
por: Acosta, Nicole, et al.
Publicado: (2021) -
Cystic Fibrosis Patients Infected With Epidemic Pseudomonas aeruginosa Strains Have Unique Microbial Communities
por: Acosta, Nicole, et al.
Publicado: (2020)